KEAP1-Nrf2 Inhibitor Screening Assay Kit

Catalog #
72020
$960 *
Size: 96 reactions
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The Keap1:Nrf2 Inhibitor Screening Assay Kit is designed for identification of inhibitors of Keap1:Nrf2 binding using fluorescence polarization (FP), a powerful tool for studying molecular interactions by monitoring the change in rotational mobility of the fluorescently-labeled molecules upon their binding to a partner. To determine the effect of the inhibitor on the formation of Keap1:Nrf2 complexes the Keap1 protein and the fluorescent Nrf2 peptide are incubated with or without the test inhibitor for 30 minutes. Changes in rotational mobility of the Nrf2 peptide are measured using a plate reader capable of measuring fluorescence polarization.

Figure 1. Illustration of the Keap1:Nrf2 Inhibitor Screening Assay Kit.

This product has been cited 12 times.

Synonyms
Kelch-like ECH-associated protein 1, Cytosolic inhibitor of Nrf2, INRF2, Kelch-like protein 19, KIAA0132, KLHL19
Product Info
Storage and Usage
Citations12
Assay Kit Format
Fluorescence Polarization
Supplied As
The 96-well format assay kit contains sufficient amounts of purified Keap1 protein, fluorochrome-conjugated Nrf2 peptide containing the ETGE motif, and assay buffer for 100 binding reactions.
Materials Required But Not Supplied

Adjustable micropipettor and sterile tips
Plate reader capable of fluorescence polarization measurements, λex = 475-495 nm, λem = 518-538 nm.

Format
Catalog # Name Amount Storage  
70040 Keap1, Human Recombinant* 30 µg -80°C Avoid freeze/ thaw cycles
79112 FAM-Nrf2 peptide (10 µM) 10 µl -80°C
79113 Keap1-Nrf2 Assay Buffer 10 ml -20°C
  BSA, 10 mg/ml 100 µl -80°C
79685 96-well black plate 1 Room Temp  

*The concentration of the protein is lot-specific and will be indicated on the tube

UniProt #
Q14145
Background

Nuclear factor erythroid 2-related factor (Nrf2) is a transcription factor that coordinates antioxidant and anti-inflammatory responses by increasing the expression of antioxidant proteins through binding to the ARE (antioxidant response element) region of their promoters. Under basal conditions, Nrf2 is retained in the cytosol by cytoskeletal Keap1, a substrate recognition subunit of a E3 ligase complex which targets Nrf2 for degradation. Exposure to oxidative stress causes the release of Nrf2 from Keap1. Nrf2 translocates to the nucleus, where it binds to AREs and induce the expression of antioxidant and phase II proteins protecting the cell from oxidative damage. Both Nrf2 and Keap1 are attractive therapeutic targets.

References

Inoyama, D., et al. 2012. J. Biomol. Screening 17(4): 435-447